Company intelligence / Profile preview

extractX

Welland, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

extractX has commercialized mobile labs that provide GMP/EU-GMP pharmaceutical-grade extraction for the processing of cannabis/hemp to distillate. Its platforms are actively installed with commercial-scale partners globally, supporting both pharma and bulk ingredient markets[1][2][4][5][6].

Industry: Contract Manufacturing Organization

Partnerships

Canurta Therapeutics (pending amalgamation/merger, LOI active as of June 2025)

Beyond the preview

Go deeper on extractX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on extractX.

Explore the full profile